In vitro study of biosynthesis of protoporphyrin IX induced by δ-aminolevulinic acid in normal and cancerous cells of the human cervix

Archives of Medical Research

Volumn 30, Issue 3, 1999, Pages 163-170

  Gallegos, Eva Ramón ^a   Deleón Rodríguez, Irma ^a   Martínez Guzmán, Lydia Alejandra ^a   Pérez Zapata, Aura Judith ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Biosynthesis; Cancerous cells; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; BILE PIGMENT; CHLOROPHYLL; CYTOCHROME; HEME; PORPHYRIN; PROTOPORPHYRIN;

ARTICLE; BIOSYNTHESIS; CANCER CELL; CANCER CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

EID: 0345593787     PISSN: 01880128     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-0128(99)00013-5     Document Type: Article

References (41)

1. Köning K., Schneckenburger H., Rück A., Steiner R. In vitro photoproduct formation during PDT with ALA-induced endogenous porphyrins. J Photochem Photobiol. 18:1993;287.
2. Gorchein A. Determination of δ-aminolaevulinic acid in biological fluids by gas-liquid chromatography with electron-capture detection. Biochem J. 219:1984;883.
3. Ratcliffe S.L., Matthews E.K. Modification of the photodynamic action of δ-aminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands. Br J Cancer. 71:1995;300.
4. Van-Hillegersberg V.R., Kort W.J., Wilson J.H. Current status of photodynamic therapy in oncology. Drug. 48:1994;510.
5. Kennedy J.C., Pottier R.H., Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX. basic principles and present clinical experience J Photochem Photobiol B: Biol. 6:1990;143.
6. Dougherty T.J., Marcus L.S. Photodynamic therapy. Eur J Cancer. 28:1992;1734.
7. Delaney T.J. Photodynamic therapy. Section E/Other therapeutic approaches. Moosa A.R., Schimpff S.C., Robson M.C. Comprensive textbook of oncology. 1991;Williams & Wilkins, Baltimore, MD. p. 675.
8. Batlle AM del C. Porphyrins, porphyrias, cancer and photodynamic therapya model for carcinogenesis. J Photochem Photobiol B:Biol. 20:1993;5.
9. Dougherty T.J., Keufman E.J., Goldfarb A., Weishaupt K.R., Boyle D., Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 38:1978;2628.
10. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? (review). Photochem Photobiol. 55:1992;145.
11. Levy J.G. Photosensitizers in photodynamic therapy. Semin Oncol. 21(Suppl 15):1994;4.
12. Loh C.S., Vernon D., MacRobert A.J., Bedwell J., Bown S.G., Brown S.B. Endogenous porphyrin distribution induced by δ-aminolevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol B:Biol. 20:1993;47.
13. Regula J., Ravi B., Bown S.G. Photodynamic therapy using δ-aminolaevulinic acid. experimental pancreatic cancer-prolonged animal survival Br J Cancer. 70:1994;254.
14. Hua Z., Gibson S.L., Foster T.H., Hilf R. Effectiveness of δ-aminolevulinic acid-induced protoporphyrin as a photoporphyrin for photodynamic therapy in vivo. Cancer Res. 55:1995;1723.
15. Rettenmaier M.A., Berman M.L., Disaia P.J., Burns R.G., Berns M.W. Photoradiation therapy of gynecologic malignancies. Gynecol Oncol. 17:1984;200.
16. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B:Biol. 14:1992;275.
17. Rebeiz N., Arkins S., Rebeiz C.A., Simon J., Zachary J.F., Kelley K.W. Induction of tumor necrosis by δ-aminolevulinic acid and 1,10-phenanthroline photodynamic therapy. Cancer Res. 56:1996;339.
18. Grant W.E., Hopper C., MacRobert A.J., Speight P.M., Bown S.G. Photodynamic therapy of oral cancer. photosensitizer for photodynamic therapy in vivo Lancet. 342:1993;147.
19. Barr H., Shepherd N.A., Dix A., Roberts D.J.H., Tan W.C., Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 348:1996;584.
20. Navone N.M., Polo F.C., Frisardi L.A., Andrade E.N., Batlle M del C.A. Heme biosynthesis in human breast cancer - mimetic in vitro studies and some heme enzymic activity levels. Int J Biochem. 22:1990;1407.
21. Benson R.C. Jr. Laser photodynamic therapy for bladder cancer. Mayo Clin Proc. 61:1986;859.
22. Lele S.B., Steven M.P., Mang T.S., Dougherty T.J., Tomczak J.M. Photodynamic therapy in gynecologic malignancies. Gynecol Oncol. 34:1989;350.
23. Kato H., Horai T., Furuse K., Fukuoka M., Suzuki S., Hiki Y., Ito Y., Mimura S., Tenjin Y., Hisazumi H. Photodynamic therapy for cancers. a clinical trial of porfimer sodium in Japan Jpn J Cancer Res. 84:1993;1209.
24. Secretaría de Salud (SSA). Norma Oficial Mexicana NOM-014-SSA2-1994. Para la Prevención, Tratamiento y Control del Cáncer del Cuello del Útero y Mamario en la Atención Primaria. México, D.F.: Publicación en el Diario Oficial de la Federación, 16 de enero de 1995 (1994). p. 1.
25. Secretaría de Salud (SSA). Manual de normas y procedimientos. Prevención de los Cánceres Cervico Uterino y Mamario. México, D.F.: Dirección de normas de prevención y control de enfermedades crónicodegenerativas; 1995. p. 3.
26. Rangel CR, Ramírez GJ, Rocha ZL, Solorza LG, Monroy GA, Martínez PRD, Trejo BC, Ibarra SMJ, Weiss SB. Establecimiento y caracterización de la línea celular CaLo y del clon KaLo, obtenidos a partir de un carcinoma de cérvix, y efecto de IL-2, II-3, GM-CSF, TNF-α e IFN-γ sobre su proliferación. Rev Inst Nal Cancerol 1993;39:1861.
27. Babich H., Borenfreund E. Neutral red assay for toxicology in vitro. Watson R.R. In vitro Methods of Toxicology. 1992;237 CRC Press, Boca Raton, FL. p.
28. Freshney R.I. Culture of specific cell types in culture of animal cells. 1991;Wiley-Liss, New York.
29. Green H. Terminal differentiation of culture human epidermal cells. Cell. 11:1977;405.
30. Green H., Thomas J. Pattern formation by cultured human epidermal cells. development of curved ridges resembling dermatoglyphs Science. 200:1978;1385.
31. Stanley M.A., Parkinson K. Growth requirements of human cervical epithelial cells in culture. Int J Cancer. 24:1979;407.
32. Piomelli S. A micromethod for free erythrocyte porphyrins. the FEP test J Lab Clin Med. 81:1973;932.
33. Ahram M., Fung C.F.W., Ward K., Kessel D. Photoproduct formation during irradiation of tissue containing protoporphyrin. J Photochem Photobiol B. 26:1994;203.
34. Iinuma S., Farshi S.S., Ortel B., Hasan T. A mechanistic study of cellular photodestruction with δ-aminolaevulinic acid-induced porphyrin. Br J Cancer. 70:1994;21.
35. Pass H.I. Photodynamic therapy in oncology. mechanisms and clinical use J Natl Cancer Inst. 85:1993;443.
36. Grandchamp B., Deybach D.C., Grelier M., De Verneuil H., Nordmann Y. Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria. Biochim Biophys Acta. 629:1980;577.
37. Rubino G.F., Rassetti L. Porphyrin metabolism in human neoplastic tissues. Panminerva Med. 8:1966;290.
38. Bugelski J.P., Porter W.C., Dougherty T.J. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res. 41:1981;4608.
39. Monteiro P.H., Bechara E.J.H., Addalla S.P.D. Free radical involvement in neurological porphyrias and lead poisoning. Mol Cell Biochem. 103:1991;73.
40. Hermes L.M., Valle G.R.V., Vercesi E.A., Bechara J.H.E. Damage to rat liver mitochondria promoted by δ-aminolevulinic acid-generated reactive oxygen species. connections with acute intermittent porphyria and lead-poisoning Biochim Biophys Acta. 1056:1991;57.
41. Borenfreund E., Shopsis C. Toxicity monitored with a correlated set of cell-culture assays. Xenobiotica. 85:1985;705.